132 deaths in Australia from the trial covid vaccination between 01/01/21 - 02/05/21, page-228

https://www.sydney.edu.au/infectious-diseases-institute/news-and-events/news/2021/08/05/should-i-wait-for-pfizer-the-case-for-astra-zeneca-now.html

Key points
* AstraZeneca (AZ) vaccine is safe and effective.
* The blood clotting condition TTS is rare, occurring in 2-3 per 100,000 people following AZ vaccination.
* Death has occurred in approx. 5% of those who had TTS: a one-in-a-million chance of dying as a result of vaccination.
* COVID-19 kills approximately 3% (1 in 35) and causes long-term illness in 10-30% of those who contract it.
* Young people are not exempt.
* The delta variant can emerge anywhere, and vaccination is essential to complement testing, contact tracing and isolation and avoid future lockdowns.